10月24日-10月27日（北京时间），2023年美国经导管心血管治疗（TCT 2023）年会将于美国加利福尼亚州旧金山拉开帷幕。

此次TCT Innovation论坛共设立了11场内容，围绕冠脉、瓣膜、左心耳封堵、TAVR脑保护和心衰等热门介入治疗方向设置了丰富讲题。严道医声网特此筛选了一些热点日程进行整合汇总。

随后，严道医声网也将持续跟踪报道，并邀请专家对一些重磅内容进行解读，日程早知道，其余最新信息邀您持续关注。

01

TCT Innovation 3

经导管主动脉瓣置换术创新

1.Featured Clinical Science in TAVR

TAVR临床科学专题

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

两种自膨式经导管心脏瓣膜治疗外科瓣膜衰败的比较：AVENGER多中心注册研究

Mortality Associated with Untreated Aortic Stenosis: Insights from Natural Language Process Big-Data Based Real-World Database

未经治疗的主动脉瓣狭窄相关死亡率：基于真实世界大数据库的自然语言见解

2.Featured Technological Trends: Next Generation TAVR Systems

特色技术趋势：下一代TAVR系统

DurAVR Transcatheter Heart Valve: Early Feasibility Study

DurAVR 经导管心脏瓣膜：早期可行性研究

Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update

机器人开发的聚合物瓣叶技术（Foldax）：技术和临床项目更新

First-in-Human XEMED TAVR Implant: An Ultra-Low Profile Modular TAVR System

XEMED TAVR系统首例临床植入：超薄型模块化TAVR系统

A Novel Transfemoral Aortic Valve Replacement System (Hanchor Valve) for Pure Native Aortic Regurgitation (PNAR)

一种用于自发性主动脉瓣关闭不全 （PNAR） 的新型经股主动脉瓣置换系统（Hanchor瓣膜）

3.Featured Technological Trends: Leaflet Modification and Other Ancillary Tools

特色技术趋势：瓣叶修复和其他辅助工具

TELLTALE - Electrosurgery Guidewire System

TELLTALE - 电外科导丝系统

Trans-Esophageal Imaging to Direct and Document Leaflet Splitting Procedures During Valve-in-Valve TAVR

用于发现和记录瓣中瓣TAVR术中瓣叶撕裂的经食管成像系统

A Novel Device to Enable Safer and More Effective Transcatheter Aortic Valve Implantation Procedures (HVT Medical)

一种可促使经导管主动脉瓣植入手术更安全、有效的的新型器械（HVT医疗）

Direct Wire Pacing for TAVR and Other Structural Procedures (Electroducer)

TAVR和其他结构性心脏病手术中的直接导线起搏（Electroducer）

TCT Innovation 4

经导管二尖瓣置换术创新

1.Innovation in TMVR: Lessons Learned and the Path Forward

TMVR的创新：经验教训和未来方向

Advances in Imaging Pre-Screening and Patient Selection

术前影像筛查和患者选择的进展

LVOT Obstruction Prevention and Management

LVOT（左心室流出道）梗阻的预防和管理

TMVR Design Iteration and Patient Eligibility

TMVR 器械设计迭代和患者选择

2.Transcatheter Mitral Valve Replacement: Technology and EFS Updates

经导管二尖瓣置换术：技术和 EFS（ 早期可行性研究）更新

One-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

经股动脉房间隔经导管二尖瓣置换术后一年结果：Intrepid TMVR 早期可行性研究结果

Cephea，AltaValve，Innovalv和Highlife早期可行性研究更新

TCT Innovation 7

经导管三尖瓣介入治疗创新

1.Featured Clinical Science in Transcatheter Tricuspid Valve Intervention

经导管三尖瓣介入治疗的临床科学专题

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

三尖瓣反流患者堪萨斯城心肌病问卷（KCCQ）的验证：Tri-QOL 研究

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

TRILUMINATE 关键影像学子研究：来自 CT 和 MRI 的见解

2.Featured Technological Trends: Transcatheter Tricuspid Valve Repair and Spacers

特色技术趋势：经导管三尖瓣修复和隔离

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

具有无创伤锚固的新型垂直垫片用于三尖瓣反流的安全性和有效性：首次人体试验（Pivot Bridge）

First-in-Human Experience with a Tricuspid Valve Flow Optimizer (TriFlow)

三尖瓣血流调节器 （TriFlow） 的首次人体研究

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

经皮治疗三尖瓣反流的 CROIVALVE Duo 系统：技术和研究更新

3.Featured Technological Trends: Transcatheter Tricuspid Valve Replacement

特色技术趋势：经导管三尖瓣置换术

One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study

多中心 TRAVEL II（ LuX-Valve Plus经导管三尖瓣置换系统）研究的一个月结果

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

一种治疗三尖瓣反流（心室内）的新型异位三尖瓣反流器械

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

新型单瓣叶三尖瓣置换系统 (Trisol）：早期临床结果

TCT Innovation 8

经导管左心耳封堵创新

1.Featured Clinical Science: Anticoagulation Post-LAAO

临床科学专题：LAAO后的抗凝治疗

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

主题演讲：LAAO后哪种抗凝剂或抗血小板方案 - 现在和未来？

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

使用双滤器栓塞保护装置进行左心耳封堵患者的组织形态学和组织病理学发现

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

非瓣膜性房颤经皮左心耳封堵术与慢性口服抗凝治疗对比的随机对照研究荟萃分析

2.Featured Clinical Science: New Generation LAAO Devices

临床科学专题：新一代LAAO器械

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

评估Laminar器械旋转闭合左心耳在非瓣膜性心房颤动患者中安全性和有效性的美国早期可行性研究

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

新型Watchman FLX Pro器械的首次人体试验：Watchman FLX Pro CT研究结果

Percutaneous Left Atrial Appendage Closure with the Lesifter Device for Stroke Prevention in Atrial Fibrillation

Lesifter器械经皮左心耳封堵术用于预防心房颤动中风

TCT Innovation 11

1.Featured Clinical Science: Stroke and Cognitive Function After TAVR

临床科学专题：TAVR术后的脑卒中和认知功能

Cardiac Output, Cerebral Blood Flow and Cognitive Functioning in Patients Undergoing Transcatheter Aortic Valve Implantation

经导管主动脉瓣植入患者的心输出量、脑血流量和认知功能

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Study Cohort

经导管主动脉瓣置换术期间的脑微出血：前瞻性磁共振成像研究队列

Brain Injury Volume by Diffusion Weighted MRI is Associated with Ischemic Stroke After TAVR: Results of a Patient-Level Pooled Analysis

弥散加权MRI的脑损伤体积与TAVR后的缺血性卒中有关：患者汇总分析的结果

2.Featured Technological Trends: Cerebral Embolic Protection and Other Ancillary Tools

特色技术趋势：脑栓塞保护装置和其他辅助工具

The Impact of Cerebral Embolic Protection Devices on The Characteristics and Outcomes of Stroke Complicating TAVR: Insights From the ASTRO-TAVI Registry

脑栓塞保护装置对TAVR术后卒中的特点和结局影响：ASTRO-TAVI登记研究

Update from the PROTECT H2H Trial with Emboliner (Case Example)

PROTECT H2HH2H研究（Emboliner）更新（病例）

Progress in Embolic Protection 1: New Debris Capture and Removal Devices

栓塞保护进展1：新型碎片捕获和清除装置

Progress in Embolic Protection 2: New Aortic Arch Deflectors Devices

栓塞保护进展2：新型主动脉弓导流装置

Permanent Filter for Stroke Prevention In Individuals With Abnormal Heart Rhythms (Vine)

用于预防心律异常患者卒中的永久过滤器（Vine）

Direct Wire Pacing for TAVR and Other Structural Procedures (Electroducer)

TAVR和其他结构性心脏病手术的直接导线起搏（Electroducer）

02

TCT Innovation 1

药物涂层球囊临床科学专题

1.New Limus vs. Paclitaxel Coated Balloon Clinical Studies

新型莫司vs.紫杉醇涂层球囊临床研究

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

首个依维莫司涂层球囊治疗冠脉支架内再狭窄的一项前瞻性、多中心、开放式、单臂研究12个月随访结果

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

在欧洲人群中使用西罗莫司或紫杉醇涂层球囊治疗新发冠脉病变的对比研究

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

一项对比西罗莫司涂层球囊与紫杉醇涂层球囊在新发小血管病变中疗效的前瞻性、多中心、随机研究：TRANSFORM I 研究

2.Emerging Concepts and Technological Trends in DCB Use

DCB（药物涂层球囊）应用的新兴概念和技术趋势

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

药物涂层球囊治疗急性冠脉综合征：多中心随机非劣效性研究（DCB-ACS试验）

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

易损脂质斑块的药物洗脱球囊治疗：DEBuT-LRP研究

Drug-Coated Balloon Angioplasty For De Novo Lesions on Left Anterior Descending Artery

药物涂层球治疗左前降支新发病变

Immediate and Follow-Up Outcomes of Drug-Coated Balloon Angioplasty in de Novo Long Lesions on Large Coronary Arteries

药物涂层球囊治疗冠脉大血管新发长病变的及时和随访结局

TCT Innovation 5

冠心病诊断与治疗创新

1.Featured Clinical Science: AI-Based CT Coronary Imaging

临床科学专题：基于AI的冠脉CT成像

Artificial Intelligence-Enabled Quantitative Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome Risk and Prevention Strategy: The EMERALD II Study

人工智能定量斑块和血流动力学分析用于预测急性冠脉综合征风险和预防策略：EMERALD II 研究

Safety and Feasibility of Planning and Performing Coronary Artery Bypass Surgery Guided Solely by Coronary Computed Tomography Angiography

仅由冠脉CTA计划和指导冠脉搭桥手术的安全性和可行性

Completeness of Revascularization by FFR-CT: Association to Patient- and Vessel-Oriented Cardiac Outcomes

FFR-CT引导的完全血运重建：以患者和血管为导向的心脏结局关联性

2.Featured Clinical Science: New DES Systems and Other Coronary Technologies

临床科学专题：新型DES（药物洗脱支架）和其他冠脉技术

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

一种新型三联药物洗脱支架（洗脱两种抗凝药物和西罗莫司）的随机临床研究：DESyne BDS Plus 研究的六个月临床和影像学结果

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

“混合”（聚合物+金属）冠动脉药物洗脱支架的首例临床应用：IonMAN研究

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

改善冠脉微血管功能障碍患者的心绞痛和冠状动脉血流储备冠状动脉窦缩小器

3.Featured Technological Trends: Percutaneous Mechanical Circulatory Support

特色技术趋势：经皮机械循环支持

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

Supira经皮心室辅助装置（Supira Medical）的早期临床结果

Magenta Elevate™: First US Experience with High-Output, Low-French Size Percutaneous Mechanical Circulatory Support

Magenta Elevate™：高输出、低导管尺寸的经皮机械循环支持的首次美国经验

TCT Innovation 9

血管内成像和生理学评估创新

1.Featured Clinical Science: Intravascular Imaging and Physiology

临床科学专题：血管内成像与生理学评估

An Optical Coherence Tomography Guided Non-Stenting Reperfusion Strategy in Patients with STEMI—A Prospective, Multi-Centre, Observational Study (EROSION II)

STEMI患者的光学相干断层扫描（OCT）引导的非支架再灌注策略——一项前瞻性、多中心、观察性研究（EROSION II）

Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial

基于OCT的功能狭窄评估：一项前瞻性多中心研究（FUSION）

2.Technological Trends: Intravascular Imaging

特色技术趋势：血管内成像

First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)

血管内荧光实时影像用于高灵敏度分子表征的冠脉粥样硬化斑块的首次临床试验（FLIGHT研究）

SpectraWAVE - HyperVue Imaging System

SpectraWAVE - HyperVue成像系统

3.Featured Technological Trends: Microvascular Function

特色技术趋势：微血管功能

Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor

使用新型光纤传感器测量心脏血管中的血流量

Microvascular Obstruction: New Developments in Cath-Lab based Detection, Diagnosis and Therapy

微血管阻塞：基于中心实验室的检测、诊断和治疗的新发展

4.Featured Technological Trends: Advanced Cardiac Imaging

特色技术趋势：心脏成像进展

Advances in Holographic Imaging for Procedural Planning and Guidance (Realview)

用于手术规划和指导的全息成像进展（Realview）

Robotically Manipulated TEE Imaging for Interventional Guidance

用于指导介入的机器人操纵TEE（经食管超声）成像

03

TCT Innovation 10

心力衰竭介入创新

1.Featured Technological Trends: Transcatheter Ventricular Remodeling

特色技术趋势：经导管心室重塑

A Left Ventricular Transcatheter Repair Device for HFrEF (Vsling)

用于HFrEF（Vsling）的经导管左心室修复器械

MIRTH Ventriculoplasty (Myocardial Intramural Remodeling by Endovenous TeTHer)

MIRTH心室成形术（由静脉内TeTHer进行的心肌壁重塑）

2.Featured Technological Trends: Pressure and Volume Management

特色技术趋势：压力和容量管理

Evaluation of The Safety & Performance of The Aquapass -Medical Device, for Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients

Aquapass器械的安全性和性能评估，通过增加血液透析患者的出汗率来增强通过皮肤的液体转移

Pre-Clinical Results With A Chronically-Adjustable And Pressure Sensing Interatrial Shunt (Adona Medical)

慢性可调和压力感应心房分流术的临床前结果（Adona医疗）

3.Featured Technological Trends: Others

特色技术趋势：其他

Transcatheter Pulmonary Artery Banding In Chronic Heart Failure [HFrEF]: Results From the First-in-Human Study

慢性心力衰竭 [HFrEF] 中的经导管肺动脉环扎术：首次人体研究结果

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: One Year Results of the REBALANCE-HF Roll-in Cohort

射血分数保留型心力衰竭中右内脏大神经血管内消融术：REBALANCE-HF Roll-in队列一年结果